| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.018 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |